Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 1
Submit an article Journal homepage
221
Views
70
CrossRef citations to date
0
Altmetric
Review

Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosis

Morie Gertz Division of HematologyCorrespondence[email protected]
,
Martha Lacy Division of Hematology
,
Angela Dispenzieri Division of Hematology
,
Suzanne Hayman Division of Hematology
,
Shaji Kumar Division of Hematology
,
Francis Buadi Division of Hematology
,
Nelson Leung Division of Hematology
&
Mark Litzow Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota
 show all
Pages 36-41 | Received 03 Aug 2007, Accepted 13 Sep 2007, Published online: 01 Jul 2009

Citations (70)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Arnt V. Kristen, Mark Rosenberg, David Lindenmaier, Corina Merkle, Henning Steen, Florian Andre, Stefan O. Schönland, Philipp A. Schnabel, Tibor Schuster, Christoph Röcken, Evangelos Giannitsis, Hugo A. Katus & Norbert Frey. (2014) Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis. Amyloid 21:3, pages 202-210.
Read now
Sajitha Sachchithanantham, Ashutosh D Wechalekar & Philip N Hawkins. (2014) An evaluation of current treatment options for immunoglobulin light-chain amyloidosis. Expert Opinion on Orphan Drugs 2:3, pages 229-244.
Read now
Giampaolo Merlini, Raymond L Comenzo, David C Seldin, Ashutosh Wechalekar & Morie A Gertz. (2014) Immunoglobulin light chain amyloidosis. Expert Review of Hematology 7:1, pages 143-156.
Read now
M. A. Gertz, M. Q. Lacy, A. Dispenzieri, S. Kumar, S. R. Hayman, F. Buadi, D. Dingli, N. Leung & W. J. Hogan. (2011) Trend toward improved day 100 and two-year survival following stem cell transplantation for AL: a comparison before and after 2006. Amyloid 18:sup1, pages 137-138.
Read now
E. Kastritis & M. A. Dimopoulos. (2011) Prognosis and risk assessment in AL amyloidosis – state of the art. Amyloid 18:sup1, pages 89-91.
Read now
Meletios Dimopoulos & Efstathios Kastritis. (2008) High dose therapy for light chain amyloidosis: Can we reduce treatment related mortality further?. Leukemia & Lymphoma 49:1, pages 4-5.
Read now

Articles from other publishers (64)

Andrew P. Jallouk & Qaiser Bashir. 2024. Manual of Hematopoietic Cell Transplantation and Cellular Therapies. Manual of Hematopoietic Cell Transplantation and Cellular Therapies 331 340 .
Joshua N. Gustine, Andrew Staron, Raphael E. Szalat, Lisa M. Mendelson, Tracy Joshi, Frederick L. Ruberg, Omar Siddiqi, Deepa M. Gopal, Camille V. Edwards, Andrea Havasi, Michelle Kaku, K. H. Vincent Lau, John L. Berk, J. Mark Sloan & Vaishali Sanchorawala. (2022) Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25‐year longitudinal study . American Journal of Hematology 97:9, pages 1189-1199.
Crossref
Federico Perfetto, Mattia Zampieri, Carlo Fumagalli, Marco Allinovi & Francesco Cappelli. (2022) Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist. Internal and Emergency Medicine 17:4, pages 957-969.
Crossref
Morie A. Gertz. (2022) Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment. American Journal of Hematology 97:6, pages 818-829.
Crossref
Emilia Czyżewska & Olga Ciepiela. (2021) The Influence of Deterioration of Kidney Function on the Diagnostic Power of Laboratory Parameters Used in the Prognostic Classification of AL Amyloidosis. Journal of Clinical Medicine 10:21, pages 4903.
Crossref
Eli Muchtar, Angela Dispenzieri, Morie A. Gertz, Shaji K. Kumar, Francis K. Buadi, Nelson Leung, Martha Q. Lacy, David Dingli, Sikander Ailawadhi, P. Leif Bergsagel, Rafael Fonseca, Suzanne R. Hayman, Prashant Kapoor, Martha Grogan, Omar F. Abou Ezzeddine, Julie L. Rosenthal, Michelle Mauermann, Mustaqueem Siddiqui, Wilson I. Gonsalves, Taxiarchis V. Kourelis, Jeremy T. Larsen, Craig B. Reeder, Rahma Warsame, Ronald S. Go, David L. Murray, Ellen D. McPhail, Surendra Dasari, Dragan Jevremovic, Robert A. Kyle, Yi Lin, John A. Lust, Stephen J. Russell, Yi Lisa Hwa, Amie L. Fonder, Miriam A. Hobbs, S. Vincent Rajkumar, Vivek Roy & Taimur Sher. (2021) Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update. Mayo Clinic Proceedings 96:6, pages 1546-1577.
Crossref
Rama Al Hamed, Abdul Hamid Bazarbachi, Ali Bazarbachi, Florent Malard, Jean-Luc Harousseau & Mohamad Mohty. (2021) Comprehensive Review of AL amyloidosis: some practical recommendations. Blood Cancer Journal 11:5.
Crossref
Vincenzo Castiglione, Maria Franzini, Alberto Aimo, Alessandro Carecci, Carlo Mario Lombardi, Claudio Passino, Claudio Rapezzi, Michele Emdin & Giuseppe Vergaro. (2021) Use of biomarkers to diagnose and manage cardiac amyloidosis. European Journal of Heart Failure 23:2, pages 217-230.
Crossref
Susan Bal & Heather J. Landau. (2020) Solid Organ Transplantation. Hematology/Oncology Clinics of North America 34:6, pages 1161-1175.
Crossref
Morie A. Gertz. (2020) Immunoglobulin light chain amyloidosis: 2020 update on diagnosis, prognosis, and treatment. American Journal of Hematology 95:7, pages 848-860.
Crossref
Eli Muchtar, Morie A. Gertz, Taxiarchis V. Kourelis, Surbhi Sidana, Ronald S. Go, Martha Q. Lacy, Francis K. Buadi, David Dingli, Suzanne R. Hayman, Prashant Kapoor, Nelson Leung, Amie Fonder, Miriam Hobbs, Yi Lisa Hwa, Wilson Gonsalves, Rahma Warsame, Stephen Russell, John A. Lust, Yi Lin, Steven Zeldenrust, S. Vincent Rajkumar, Robert A. Kyle, Shaji K. Kumar & Angela Dispenzieri. (2019) Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis. Leukemia 34:4, pages 1135-1143.
Crossref
Iuliana Vaxman, Angela Dispenzieri, Eli Muchtar & Morie Gertz. (2020) New developments in diagnosis, risk assessment and management in systemic amyloidosis. Blood Reviews 40, pages 100636.
Crossref
Adam Castaño & Mathew S. Maurer. 2020. Heart Failure: a Companion to Braunwald's Heart Disease. Heart Failure: a Companion to Braunwald's Heart Disease 301 310.e3 .
M. Hasib Sidiqi, Kalyan Nadiminti, Abdullah S. Al Saleh, Kapil Meleveedu, Francis K. Buadi, Angela Dispenzieri, Rahma Warsame, Martha Q. Lacy, David Dingli, Nelson Leung, Wilson I. Gonsalves, Prashant Kapoor, Taxiarchis V. Kourelis, William J. Hogan, Shaji K. Kumar & Morie A. Gertz. (2019) Autologous stem cell transplantation in patients with AL amyloidosis with impaired renal function. Bone Marrow Transplantation 54:11, pages 1775-1779.
Crossref
Surbhi Sidana, M. Hasib Sidiqi, Angela Dispenzieri, Francis K. Buadi, Martha Q. Lacy, Eli Muchtar, David Dingli, Suzanne R. Hayman, Wilson I. Gonsalves, Prashant Kapoor, Nelson Leung, Rahma Warsame, Taxiarchis V. Kourelis, Robert C. Wolf, William J. Hogan, Shaji K. Kumar & Morie A. Gertz. (2019) Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis. American Journal of Hematology 94:9, pages 1020-1026.
Crossref
Abdullah S. Al Saleh, M. Hasib Sidiqi, Eli Muchtar, Angela Dispenzieri, Francis K. Buadi, David Dingli, Martha Q. Lacy, Rahma M. Warsame, Wilson I. Gonsalves, Taxiarchis V. Kourelis, William J. Hogan, Suzanne R. Hayman, Prashant Kapoor, Shaji K. Kumar & Morie A. Gertz. (2019) Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved. Biology of Blood and Marrow Transplantation 25:8, pages 1520-1525.
Crossref
Eli Muchtar, Shaji K. Kumar, Morie A. Gertz, Martha Grogan, Omar F. AbouEzzeddine, Allan S. Jaffe & Angela Dispenzieri. (2019) Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assay. Blood 133:7, pages 763-766.
Crossref
Iuliana Vaxman & Morie Gertz. (2019) Recent Advances in the Diagnosis, Risk Stratification, and Management of Systemic Light-Chain Amyloidosis. Acta Haematologica 141:2, pages 93-106.
Crossref
Morie A. Gertz. (2018) Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment. American Journal of Hematology 93:9, pages 1169-1180.
Crossref
M Hasib Sidiqi, Mohammed A. Aljama, Francis K. Buadi, Rahma M. Warsame, Martha Q. Lacy, Angela Dispenzieri, David Dingli, Wilson I. Gonsalves, Shaji Kumar, Prashant Kapoor, Taxiarchis Kourelis, William J. Hogan & Morie A. Gertz. (2018) Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over Time. Journal of Clinical Oncology 36:13, pages 1323-1329.
Crossref
Anit K. Mankad, Isata Sesay & Keyur B. Shah. (2017) Light-chain cardiac amyloidosis. Current Problems in Cancer 41:2, pages 144-156.
Crossref
Yi L. Hwa, Shaji K. Kumar, Morie A. Gertz, Martha Q. Lacy, Francis K. Buadi, Taxiarchis V. Kourelis, Wilson I. Gonsalves, S. Vincent Rajkumar, Ronald S. Go, Nelson Leung, Prashant Kapoor, David Dingli, Robert A. Kyle, Stephen Russell, John A. lust, Suzanne R. Hayman, Yi Lin, Steven Zeldenrust & Angela Dispenzieri. (2016) Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation. American Journal of Hematology 91:10, pages 984-988.
Crossref
Morie A. Gertz. (2016) Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment. American Journal of Hematology 91:9, pages 947-956.
Crossref
Angela Dispenzieri & Giampaolo Merlini. 2016. Plasma Cell Dyscrasias. Plasma Cell Dyscrasias 273 318 .
Noffar Bar, Terri L. Parker & Madhav V. Dhodapkar. (2015) Stem-Cell Transplantation for Amyloidosis: Improving Outcomes but Not for the Faint of Heart. Journal of Clinical Oncology 33:32, pages 3689-3690.
Crossref
Angela Dispenzieri, Francis Buadi, Shaji K. Kumar, Craig B. Reeder, Tamur Sher, Martha Q. Lacy, Robert A. Kyle, Joseph R. Mikhael, Vivek Roy, Nelson Leung, Martha Grogan, Prashant Kapoor, John A. Lust, David Dingli, Ronald S. Go, Yi Lisa Hwa, Suzanne R. Hayman, Rafael Fonseca, Sikander Ailawadhi, P. Leif Bergsagel, Ascher Chanan-Khan, S. Vincent Rajkumar, Stephen J. Russell, Keith Stewart, Steven R. Zeldenrust & Morie A. Gertz. (2015) Treatment of Immunoglobulin Light Chain Amyloidosis. Mayo Clinic Proceedings 90:8, pages 1054-1081.
Crossref
N. Weber, P. Mollee, B. Augustson, R. Brown, L. Catley, J. Gibson, S. Harrison, P. J. Ho, N. Horvath, W. Jaksic, D. Joshua, H. Quach, A. W. Roberts, A. Spencer, J. Szer, D. Talaulikar, B. To, A. Zannettino & H. M. Prince. (2015) Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group. Internal Medicine Journal 45:4, pages 371-382.
Crossref
Efstathios Kastritis, Maria Roussou, Maria Gavriatopoulou, Magdalini Migkou, Despina Kalapanida, Constantinos Pamboucas, Elisavet Kaldara, Argyrios Ntalianis, Erasmia Psimenou, Savvas T. Toumanidis, Anna Tasidou, Evangelos Terpos & Meletios A. Dimopoulos. (2015) Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies. American Journal of Hematology 90:4, pages E60-E65.
Crossref
Martha Grogan & Angela Dispenzieri. (2014) Natural history and therapy of AL cardiac amyloidosis. Heart Failure Reviews 20:2, pages 155-162.
Crossref
Morie A. Gertz, Angela Dispenzieri & Taimur Sher. (2014) Pathophysiology and treatment of cardiac amyloidosis. Nature Reviews Cardiology 12:2, pages 91-102.
Crossref
Lærke Marie Nelson, Finn Gustafsson & Peter Gimsing. (2015) Characteristics and Long-Term Outcome of Patients with Systemic Immunoglobulin Light-Chain Amyloidosis. Acta Haematologica 133:4, pages 336-346.
Crossref
Vaishali Sanchorawala. (2014) High Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation in AL Amyloidosis. Hematology/Oncology Clinics of North America 28:6, pages 1131-1144.
Crossref
Morie A. Gertz. (2014) Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment. American Journal of Hematology 89:12, pages 1132-1140.
Crossref
S Parmar, P Kongtim, R Champlin, Y Dinh, Y Elgharably, M Wang, Q Bashir, J J Shah, N Shah, U Popat, S A Giralt, R Z Orlowski & M H Qazilbash. (2014) Auto-SCT improves survival in systemic light chain amyloidosis: a retrospective analysis with 14-year follow-up. Bone Marrow Transplantation 49:8, pages 1036-1041.
Crossref
A Dispenzieri, M A Gertz, S K Kumar, M Q Lacy, R A Kyle, A K Saenger, M Grogan, S R Zeldenrust, S R Hayman, F Buadi, P R Greipp, N Leung, S R Russell, D Dingli, J A Lust, S V Rajkumar & A S Jaffe. (2014) High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis. Heart 100:5, pages 383-388.
Crossref
Federico Perfetto, Franco Bergesio, Michele Emdin & Francesco Cappelli. (2014) Troponins in cardiac amyloidosis: multipurpose markers. Nature Reviews Cardiology 11:3, pages 179-179.
Crossref
Morie A. Gertz & Steven R. Zeldenrust. 2014. Multiple Myeloma. Multiple Myeloma 265 282 .
A Dispenzieri, K Seenithamby, M Q Lacy, S K Kumar, F K Buadi, S R Hayman, D Dingli, M R Litzow, D A Gastineau, D J Inwards, I N Micallef, S M Ansell, P B Johnston, L F Porrata, M M Patnaik, W J Hogan & M A A Gertz. (2013) Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center.. Bone Marrow Transplantation 48:10, pages 1302-1307.
Crossref
M Rosenzweig, S Giralt & H Landau. (2012) Light-chain amyloidosis: SCT, novel agents and beyond. Bone Marrow Transplantation 48:8, pages 1022-1027.
Crossref
Morie A. Gertz. (2013) Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment. American Journal of Hematology 88:5, pages 416-425.
Crossref
M A Gertz, M Q Lacy, A Dispenzieri, S K Kumar, D Dingli, N Leung, W J Hogan, F K Buadi & S R Hayman. (2012) Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis. Bone Marrow Transplantation 48:4, pages 557-561.
Crossref
Moshe E. Gatt & Giovanni Palladini. (2013) Light chain amyloidosis 2012: a new era. British Journal of Haematology 160:5, pages 582-598.
Crossref
Morie A. Gertz & Robert A. Kyle. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 729 750 .
L. Kristin Newby, Robert L. Jesse, Joseph D. Babb, Robert H. Christenson, Thomas M. De Fer, George A. Diamond, Francis M. Fesmire, Stephen A. Geraci, Bernard J. Gersh, Greg C. Larsen, Sanjay Kaul, Charles R. McKay, George J. Philippides, William S. Weintraub, Robert A. Harrington, Deepak L. Bhatt, Jeffrey L. Anderson, Eric R. Bates, Charles R. Bridges, Mark J. Eisenberg, Victor A. Ferrari, John D. Fisher, Mario J. Garcia, Timothy J. Gardner, Federico Gentile, Michael F. Gilson, Adrian F. Hernandez, Mark A. Hlatky, Alice K. Jacobs, Sanjay Kaul, Jane A. Linderbaum, David J. Moliterno, Debabrata Mukherjee, Robert S. Rosenson, James H. Stein, Howard H. Weitz & Deborah J. Wesley. (2012) ACCF 2012 Expert Consensus Document on Practical Clinical Considerations in the Interpretation of Troponin Elevations. Journal of the American College of Cardiology 60:23, pages 2427-2463.
Crossref
Angela Dispenzieri, Morie A. Gertz & Francis Buadi. (2012) What do I need to know about immunoglobulin light chain (AL) amyloidosis?. Blood Reviews 26:4, pages 137-154.
Crossref
Peter Mollee, Campbell Tiley, Ilona Cunningham, John Moore, H. Miles Prince, Paul Cannell, Steve Gibbons, Jill Tate, Sanjoy Paul, Helen Mar Fan & Devinder S. Gill. (2012) A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis. British Journal of Haematology 157:6, pages 766-769.
Crossref
Stephen A. Geraci. (2012) Canary in the Coal Mine: Cardiac Troponins in Noncoronary Diseases. The American Journal of Medicine 125:6, pages 527-528.
Crossref
Sumit MadanShaji K. KumarAngela DispenzieriMartha Q. LacySuzanne R. HaymanFrancis K. BuadiDavid DingliS. Vincent RajkumarWilliam J. HoganNelson Leung, Martha Grogan & Morie A. Gertz. (2012) High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement. Blood 119:5, pages 1117-1122.
Crossref
M A Gertz. (2011) How to manage primary amyloidosis. Leukemia 26:2, pages 191-198.
Crossref
Morie A. Gertz. (2012) Immunoglobulin light chain amyloidosis: 2012 update on diagnosis, prognosis, and treatment. American Journal of Hematology 87:2, pages 183-189.
Crossref
Michael Rosenzweig & Heather Landau. (2011) Light chain (AL) amyloidosis: update on diagnosis and management. Journal of Hematology & Oncology 4:1.
Crossref
M A Gertz, M Q Lacy, A Dispenzieri, S K Kumar, F K Buadi, D Dingli, N Leung, W J Hogan & S R Hayman. (2010) Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006. Bone Marrow Transplantation 46:7, pages 970-975.
Crossref
. (2011) Abstracts. Amyloid 18:Suppl. 1, pages 6-238.
Crossref
Giovanni Palladini & Giampaolo Merlini. (2011) Transplantation vs. conventional-dose therapy for amyloidosis. Current Opinion in Oncology 23:2, pages 214-220.
Crossref
Morie A. Gertz. (2011) Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk‐stratification, and management. American Journal of Hematology 86:2, pages 180-186.
Crossref
Shaji K. Kumar, Morie A. Gertz, Martha Q. Lacy, David Dingli, Suzanne R. Hayman, Francis K. Buadi, Kristen Short-Detweiler, Steven R. Zeldenrust, Nelson Leung, Philip R. Greipp, John A. Lust, Stephen J. Russell, Robert A. Kyle, S. Vincent Rajkumar & Angela Dispenzieri. (2011) Recent Improvements in Survival in Primary Systemic Amyloidosis and the Importance of an Early Mortality Risk Score. Mayo Clinic Proceedings 86:1, pages 12-18.
Crossref
Morie A. Gertz & Raymond Comenzo. 2011. Bortezomib in the Treatment of Multiple Myeloma. Bortezomib in the Treatment of Multiple Myeloma 135 148 .
Angela Dispenzieri & Suzanne R. Hayman. 2011. Management of Hematologic Malignancies. Management of Hematologic Malignancies 184 206 .
Arnt V. KristenEvangelos GiannitsisStephanie LehrkeUte Hegenbart, Matthias KonstandinDavid LindenmaierCorina MerkleStefan HardtPhilipp A. Schnabel, Christoph Röcken, Stefan O. Schonland, Anthony D. Ho, Thomas J. DenglerHugo A. Katus. (2010) Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay. Blood 116:14, pages 2455-2461.
Crossref
Jayesh Mehta, Angela Dispenzieri & Morie A. Gertz. (2010) High-Dose Chemotherapy with Autotransplantation in AL Amyloidosis: A Flawed Meta-analysis. Biology of Blood and Marrow Transplantation 16:1, pages 138-140.
Crossref
Adam D. Cohen & Raymond L. Comenzo. 2010. Amyloidosis. Amyloidosis 165 177 .
Raymond L. Comenzo. (2009) How I treat amyloidosis. Blood 114:15, pages 3147-3157.
Crossref
Morie A. Gertz & Steven R. Zeldenrust. (2009) Treatment of immunoglobulin light chain amyloidosis. Current Hematologic Malignancy Reports 4:2, pages 91-98.
Crossref
Morie A Gertz. (2008) Amyloidosis: diagnosis and prognosis. Future Rheumatology 3:4, pages 369-380.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.